Skip to content

CMC 1 total joint arthroplasty: rehabilitation or education? A controlled trial.

CMC 1 total joint arthroplasty: rehabilitation or education? A controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27423
Enrollment
62
Registered
2019-04-10
Start date
2018-09-03
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the first carpometacarpal (CMC1) joint

Interventions

A historic cohort (resulting from a completed randomized clinical trial ) with standard care (supervised rehabilitation with hand therapy) will be compared with a prospective cohort of people who only

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 40 years or older with CMC1 osteoarthritis Eaton Glickel stage II or III (clinical and X-ray findings) who will receive a total CMC1 joint arthroplasty (Maïa® prosthesis, Groupe Lépine, Genay, France) .

Exclusion criteria

Exclusion criteria: - Surgery for trapeziometacarpal osteoarthritis on the same hand in the past. - Total joint arthroplasty on the contralateral hand in the past. - Secondary trapeziometacarpal osteoarthritis as result of trauma, rheumatoid arthritis, systemic lupus or gout. - Symptomatic carpal tunnel syndrome in same hand. - Symptomatic Quervain's tenosynovitis in same hand. - Neurological or other disorders of the affected side that can influence postoperative rehabilitation. - Insufficient knowledge of Dutch language

Design outcomes

Primary

MeasureTime frame
Daily hand function in patients with a total CMC1 joint arthroplasty after 3 months postoperatively, measured with the total score of the Michigan Hand Outcomes Questionnaire (MHOQ).

Secondary

MeasureTime frame
Pain, thumb range of motion, grip- and pinchstrength, complications, additional therapist- or surgeon visits, time to return to work and patient satisfaction.

Contacts

Public ContactEDJ Bonhof-Jansen

Isala

e.d.j.bonhof@isala.nl038-4247182

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)